BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24252647)

  • 1. Promoter DNA methylation regulates progranulin expression and is altered in FTLD.
    Banzhaf-Strathmann J; Claus R; Mücke O; Rentzsch K; van der Zee J; Engelborghs S; De Deyn PP; Cruts M; van Broeckhoven C; Plass C; Edbauer D
    Acta Neuropathol Commun; 2013 May; 1():16. PubMed ID: 24252647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration.
    Galimberti D; D'Addario C; Dell'osso B; Fenoglio C; Marcone A; Cerami C; Cappa SF; Palazzo MC; Arosio B; Mari D; Maccarrone M; Bresolin N; Altamura AC; Scarpini E
    Neurol Sci; 2013 Jun; 34(6):899-903. PubMed ID: 22797721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.
    Chen-Plotkin AS; Xiao J; Geser F; Martinez-Lage M; Grossman M; Unger T; Wood EM; Van Deerlin VM; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2010 Jan; 119(1):111-22. PubMed ID: 19649643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.
    Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
    Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
    Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.
    Götzl JK; Mori K; Damme M; Fellerer K; Tahirovic S; Kleinberger G; Janssens J; van der Zee J; Lang CM; Kremmer E; Martin JJ; Engelborghs S; Kretzschmar HA; Arzberger T; Van Broeckhoven C; Haass C; Capell A
    Acta Neuropathol; 2014; 127(6):845-60. PubMed ID: 24619111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
    Pottier C; Zhou X; Perkerson RB; Baker M; Jenkins GD; Serie DJ; Ghidoni R; Benussi L; Binetti G; López de Munain A; Zulaica M; Moreno F; Le Ber I; Pasquier F; Hannequin D; Sánchez-Valle R; Antonell A; Lladó A; Parsons TM; Finch NA; Finger EC; Lippa CF; Huey ED; Neumann M; Heutink P; Synofzik M; Wilke C; Rissman RA; Slawek J; Sitek E; Johannsen P; Nielsen JE; Ren Y; van Blitterswijk M; DeJesus-Hernandez M; Christopher E; Murray ME; Bieniek KF; Evers BM; Ferrari C; Rollinson S; Richardson A; Scarpini E; Fumagalli GG; Padovani A; Hardy J; Momeni P; Ferrari R; Frangipane F; Maletta R; Anfossi M; Gallo M; Petrucelli L; Suh E; Lopez OL; Wong TH; van Rooij JGJ; Seelaar H; Mead S; Caselli RJ; Reiman EM; Noel Sabbagh M; Kjolby M; Nykjaer A; Karydas AM; Boxer AL; Grinberg LT; Grafman J; Spina S; Oblak A; Mesulam MM; Weintraub S; Geula C; Hodges JR; Piguet O; Brooks WS; Irwin DJ; Trojanowski JQ; Lee EB; Josephs KA; Parisi JE; Ertekin-Taner N; Knopman DS; Nacmias B; Piaceri I; Bagnoli S; Sorbi S; Gearing M; Glass J; Beach TG; Black SE; Masellis M; Rogaeva E; Vonsattel JP; Honig LS; Kofler J; Bruni AC; Snowden J; Mann D; Pickering-Brown S; Diehl-Schmid J; Winkelmann J; Galimberti D; Graff C; Öijerstedt L; Troakes C; Al-Sarraj S; Cruchaga C; Cairns NJ; Rohrer JD; Halliday GM; Kwok JB; van Swieten JC; White CL; Ghetti B; Murell JR; Mackenzie IRA; Hsiung GR; Borroni B; Rossi G; Tagliavini F; Wszolek ZK; Petersen RC; Bigio EH; Grossman M; Van Deerlin VM; Seeley WW; Miller BL; Graff-Radford NR; Boeve BF; Dickson DW; Biernacka JM; Rademakers R
    Lancet Neurol; 2018 Jun; 17(6):548-558. PubMed ID: 29724592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration.
    Chen-Plotkin AS; Geser F; Plotkin JB; Clark CM; Kwong LK; Yuan W; Grossman M; Van Deerlin VM; Trojanowski JQ; Lee VM
    Hum Mol Genet; 2008 May; 17(10):1349-62. PubMed ID: 18223198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.
    Chen-Plotkin AS; Martinez-Lage M; Sleiman PM; Hu W; Greene R; Wood EM; Bing S; Grossman M; Schellenberg GD; Hatanpaa KJ; Weiner MF; White CL; Brooks WS; Halliday GM; Kril JJ; Gearing M; Beach TG; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Pickering-Brown SM; Snowden J; van Swieten JC; Heutink P; Seelaar H; Murrell JR; Ghetti B; Spina S; Grafman J; Kaye JA; Woltjer RL; Mesulam M; Bigio E; Lladó A; Miller BL; Alzualde A; Moreno F; Rohrer JD; Mackenzie IR; Feldman HH; Hamilton RL; Cruts M; Engelborghs S; De Deyn PP; Van Broeckhoven C; Bird TD; Cairns NJ; Goate A; Frosch MP; Riederer PF; Bogdanovic N; Lee VM; Trojanowski JQ; Van Deerlin VM
    Arch Neurol; 2011 Apr; 68(4):488-97. PubMed ID: 21482928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
    Finch N; Carrasquillo MM; Baker M; Rutherford NJ; Coppola G; Dejesus-Hernandez M; Crook R; Hunter T; Ghidoni R; Benussi L; Crook J; Finger E; Hantanpaa KJ; Karydas AM; Sengdy P; Gonzalez J; Seeley WW; Johnson N; Beach TG; Mesulam M; Forloni G; Kertesz A; Knopman DS; Uitti R; White CL; Caselli R; Lippa C; Bigio EH; Wszolek ZK; Binetti G; Mackenzie IR; Miller BL; Boeve BF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Geschwind DH; Rademakers R
    Neurology; 2011 Feb; 76(5):467-74. PubMed ID: 21178100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Loss-of-Function GRN Mutation p.(Tyr229*): Clinical and Neuropathological Features.
    Kuuluvainen L; Pöyhönen M; Pasanen P; Siitonen M; Rummukainen J; Tienari PJ; Paetau A; Myllykangas L
    J Alzheimers Dis; 2017; 55(3):1167-1174. PubMed ID: 27767988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced secretion and altered proteolytic processing caused by missense mutations in progranulin.
    Kleinberger G; Capell A; Brouwers N; Fellerer K; Sleegers K; Cruts M; Van Broeckhoven C; Haass C
    Neurobiol Aging; 2016 Mar; 39():220.e17-26. PubMed ID: 26811050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations.
    Pottier C; Mateiu L; Baker MC; DeJesus-Hernandez M; Teixeira Vicente C; Finch NA; Tian S; van Blitterswijk M; Murray ME; Ren Y; Petrucelli L; Oskarsson B; Biernacka JM; Graff-Radford NR; Boeve BF; Petersen RC; Josephs KA; Asmann YW; Dickson DW; Rademakers R
    Brain; 2022 Jul; 145(7):2472-2485. PubMed ID: 34918030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration.
    Chiang HH; Forsell C; Lilius L; Öijerstedt L; Thordardottir S; Shanmugarajan K; Westerlund M; Nennesmo I; Thonberg H; Graff C
    Eur J Hum Genet; 2013 Nov; 21(11):1260-5. PubMed ID: 23463024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice.
    Götzl JK; Colombo AV; Fellerer K; Reifschneider A; Werner G; Tahirovic S; Haass C; Capell A
    Mol Neurodegener; 2018 Sep; 13(1):48. PubMed ID: 30180904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
    Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM
    J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progranulin genetic screening in frontotemporal lobar degeneration patients from central Italy.
    Bagnoli S; Piaceri I; Tedde A; Piacentini S; Nannucci S; Bracco L; Sorbi S; Nacmias B
    Cell Mol Neurobiol; 2012 Jan; 32(1):13-6. PubMed ID: 21800185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human genetics as a tool to identify progranulin regulators.
    Nicholson AM; Finch NA; Rademakers R
    J Mol Neurosci; 2011 Nov; 45(3):532-7. PubMed ID: 21626010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
    Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
    J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progranulin transcripts with short and long 5' untranslated regions (UTRs) are differentially expressed via posttranscriptional and translational repression.
    Capell A; Fellerer K; Haass C
    J Biol Chem; 2014 Sep; 289(37):25879-89. PubMed ID: 25056957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.